Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A23685 | 23565376 | Indian J Endocrinol Metab | Childhood obesity: Determinants, evaluation, and prevention. | 2012 | Details |
| A23686 | 23564711 | Radiology | Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography. | 2013 | Details |
| A23687 | 23564467 | Hepatology | Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent. | 2013 | Details |
| A23690 | 23562079 | Cell Metab | Molecular and genetic crosstalks between mTOR and ERRα are key determinants of rapamycin-induced nonalcoholic fatty liver. | 2013 | Details |
| A23691 | 23560860 | Liver Int | Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease. | 2013 | Details |
| A23692 | 23560827 | Liver Int | The role of transient elastography in the detection of liver disease in patients with chronic pancreatitis. | 2013 | Details |
| A23693 | 23560695 | J Diabetes | Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology. | 2013 | Details |
| A23694 | 23560443 | Int J Exp Pathol | Inhibition of Glutaminyl Cyclases alleviates CCL2-mediated inflammation of non-alcoholic fatty liver disease in mice. | 2013 | Details |
| A23695 | 23558563 | Dig Dis Sci | Iron overload causes oxidative stress and impaired insulin signaling in AML-12 hepatocytes. | 2013 | Details |
| A23696 | 23558065 | Hepatobiliary Pancreat Dis Int | Therapeutic approaches to non-alcoholic fatty liver disease: past achievements and future challenges. | 2013 | Details |
| A23697 | 23557879 | Nutr Metab Cardiovasc Dis | The fatty liver index is associated with increased mortality in subjects referred to coronary angiography. | 2013 | Details |
| A23698 | 23557869 | J Hepatol | Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease. | 2013 | Details |
| A23699 | 23556042 | World J Hepatol | Silymarin in non alcoholic fatty liver disease. | 2013 | Details |
| A23700 | 23555982 | PLoS One | Long-term effect of bariatric surgery on liver enzymes in the Swedish Obese Subjects (SOS) study. | 2013 | Details |
| A23701 | 23555578 | PLoS One | NIKEI: a new inexpensive and non-invasive scoring system to exclude advanced fibrosis in patients with NAFLD. | 2013 | Details |
| A23702 | 23554890 | PLoS One | Oral probiotic microcapsule formulation ameliorates non-alcoholic fatty liver disease in Bio F1B Golden Syrian hamsters. | 2013 | Details |
| A23703 | 23554788 | J Biomed Res | Lipoprotein metabolism in nonalcoholic fatty liver disease. | 2012 | Details |
| A23704 | 23553630 | J Biol Chem | Metabolomic profiling reveals a role for caspase-2 in lipoapoptosis. | 2013 | Details |
| A23705 | 23551911 | Hepatol Res | Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseases. | 2013 | Details |
| A23706 | 23548993 | Tumori | Linking nonalcoholic fatty liver disease to hepatocellular carcinoma: from bedside to bench and back. | 2013 | Details |
| A23707 | 23548687 | Digestion | Clinical characteristics and time trends in etiology of hepatocellular cancer in Germany. | 2013 | Details |
| A23708 | 23548578 | Am J Surg | Survival after surgery for hepatocellular carcinoma in relation to presence or absence of viral infection. | 2013 | Details |
| A23709 | 23548197 | J Hepatol | Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats. | 2013 | Details |
| A23710 | 23547829 | Nutr J | Plasmatic higher levels of homocysteine in non-alcoholic fatty liver disease (NAFLD). | 2013 | Details |
| A23711 | 23546700 | Dig Dis Sci | The prevalence and clinical correlates of nonalcoholic fatty liver disease (NAFLD) in African Americans: the multiethnic study of atherosclerosis (MESA). | 2013 | Details |
| A23712 | 23545714 | Am J Gastroenterol | The Western dietary pattern is prospectively associated with nonalcoholic fatty liver disease in adolescence. | 2013 | Details |
| A23713 | 23545713 | Am J Gastroenterol | Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population. | 2013 | Details |
| A23714 | 23545492 | Genomics | Genomic aspects of NAFLD pathogenesis. | 2013 | Details |
| A23715 | 23544853 | Metab Syndr Relat Disord | Effects of sitagliptin on nonalcoholic fatty liver disease in diet-induced obese rats. | 2013 | Details |
| A23716 | 23544269 | Nagoya J Med Sci | Simple and rapid quantitation of 21 bile acids in rat serum and liver by UPLC-MS-MS: effect of high fat diet on glycine conjugates of rat bile acids. | 2013 | Details |
| A23717 | 23542537 | Biochem Pharmacol | The liver X receptor: a master regulator of the gut-liver axis and a target for non alcoholic fatty liver disease. | 2013 | Details |
| A23718 | 25016754 | Lik Sprava | [Liver stiffness in animals with glutamate-induced obesity (according to shear wave ultrasound elastography)]. | 2014 | Details |
| A23719 | 23538296 | JPEN J Parenter Enteral Nutr | Nonalcoholic fatty liver disease: for better or worse, blame the gut microbiota? | 2013 | Details |
| A23720 | 23538201 | J Pharmacol Exp Ther | Ezetimibe increases hepatic iron levels in mice fed a high-fat diet. | 2013 | Details |
| A23721 | 23537653 | Biochem Biophys Res Commun | Hydrogen peroxide impairs autophagic flux in a cell model of nonalcoholic fatty liver disease. | 2013 | Details |
| A23722 | 23537027 | Appl Physiol Nutr Metab | Nonalcoholic fatty liver disease is associated with lower hepatic and erythrocyte ratios of phosphatidylcholine to phosphatidylethanolamine. | 2012 | Details |
| A23723 | 23535911 | Hum Genet | Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan. | 2013 | Details |
| A23724 | 23534297 | Med Pregl | [Cardiovascular disease risk factors in patients with non-alcoholic fatty liver disease]. | 2013 | Details |
| A23725 | 23532271 | Braz J Med Biol Res | Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver. | 2013 | Details |
| A23726 | 23531105 | Lipids Health Dis | Rosiglitazone and bezafibrate modulate gene expression in a rat model of non-alcoholic fatty liver disease--a historical prospective. | 2013 | Details |
| A23727 | 23530957 | BMC Pediatr | Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets. | 2013 | Details |
| A23728 | 23529597 | Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz | [Non-alcoholic fatty liver disease in obese children and adolescents]. | 2013 | Details |
| A23729 | 23529326 | Rom J Morphol Embryol | Correlations between anthropometric and serologic elements of metabolic syndrome and histopathologic features of nonalcoholic fatty liver disease. | 2013 | Details |
| A23730 | 23528177 | Annu Rev Nutr | Fatty acid-regulated transcription factors in the liver. | 2013 | Details |
| A23731 | 23528112 | Scand J Urol | Non-alcoholic fatty liver disease is associated with benign prostate hyperplasia in men and with overactive bladder in women. | 2013 | Details |
| A23732 | 23525389 | J Ultrasound Med | Targeted hepatic sonography during clinic visits for detection of fatty liver in overweight children: a pilot study. | 2013 | Details |
| A23733 | 23523139 | Diabetes Metab | MRI measurement of liver fat content predicts the metabolic syndrome. | 2013 | Details |
| A23734 | 23522007 | Psychol Med | Elevated alanine aminotransferase independently predicts new onset of depression in employees undergoing health screening examinations. | 2013 | Details |
| A23736 | 23519653 | Hepatol Int | Hepatic angiogenesis and fibrosis are common features in morbidly obese patients. | 2011 | Details |
| A23737 | 23518490 | J Pediatr Gastroenterol Nutr | Serum bilirubin level is inversely associated with nonalcoholic steatohepatitis in children. | 2013 | Details |
| A23738 | 23518484 | J Pediatr Gastroenterol Nutr | A multidisciplinary clinical program is effective in stabilizing BMI and reducing transaminase levels in pediatric patients with NAFLD. | 2013 | Details |
| A23739 | 23517307 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease in diabetics--prevalence and predictive factors in a multiracial hospital clinic population in Malaysia. | 2013 | Details |
| A23740 | 23516679 | Can J Gastroenterol | A health technology assessment of transient elastography in adult liver disease. | 2013 | Details |
| A23741 | 23516571 | PLoS One | Systems biology elucidates common pathogenic mechanisms between nonalcoholic and alcoholic-fatty liver disease. | 2013 | Details |
| A23742 | 23516172 | World J Gastrointest Pharmacol Ther | Inhibition of apoptosis in the management of nonalcoholic fatty liver disease. | 2013 | Details |
| A23743 | 23515587 | Eur J Nutr | Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways. | 2013 | Details |
| A23744 | 23514999 | Minerva Med | Recurrent hepatitis C and non-alcoholic fatty liver disease in transplanted patients: a review. | 2013 | Details |
| A23745 | 23514731 | Diabetes Care | Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver. | 2013 | Details |
| A23746 | 23512965 | Obesity (Silver Spring) | Metabolomic signatures in lipid-loaded HepaRGs reveal pathways involved in steatotic progression. | 2013 | Details |
| A23747 | 23512881 | Obesity (Silver Spring) | A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population. | 2013 | Details |
| A23748 | 23512725 | Obesity (Silver Spring) | Racial differences in nonalcoholic fatty liver disease in the U.S. population. | 2013 | Details |
| A23749 | 23512600 | Obesity (Silver Spring) | Serum hepcidin levels are associated with obesity but not liver disease. | 2013 | Details |
| A23750 | 23510779 | Gene | Association of the I148M/PNPLA3 variant with elevated alanine transaminase levels in normal-weight and overweight/obese Mexican children. | 2013 | Details |
| A23751 | 23510198 | Diabet Med | Liver enzymes, race, gender and diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study. | 2013 | Details |
| A23752 | 23510120 | Hepatol Res | Clinical usefulness of non-protein respiratory quotient measurement in non-alcoholic fatty liver disease. | 2013 | Details |
| A23753 | 23510093 | Hepatol Res | Novel effect of ezetimibe to inhibit the development of non-alcoholic fatty liver disease in Fatty Liver Shionogi mouse. | 2013 | Details |
| A23754 | 23509615 | J Obes | Platelet counts and liver enzymes after bariatric surgery. | 2013 | Details |
| A23757 | 23508103 | Mol Cell Biol | Activation of the aryl hydrocarbon receptor sensitizes mice to nonalcoholic steatohepatitis by deactivating mitochondrial sirtuin deacetylase Sirt3. | 2013 | Details |
| A23758 | 23507799 | Nat Rev Gastroenterol Hepatol | Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. | 2013 | Details |
| A23759 | 23507574 | Endocrinology | Identification of chemerin as a novel FXR target gene down-regulated in the progression of nonalcoholic steatohepatitis. | 2013 | Details |
| A23760 | 23505183 | Obesity (Silver Spring) | Retinol binding protein-4 circulating levels were higher in nonalcoholic fatty liver disease vs. histologically normal liver from morbidly obese women. | 2013 | Details |
| A23761 | 23505022 | Proteomics | Proteomic profile of carbonylated proteins in rat liver: exercise attenuated oxidative stress may be involved in fatty liver improvement. | 2013 | Details |
| A23762 | 23504985 | Pediatr Obes | Epicardial adipose tissue and cardiometabolic risk factors in overweight and obese children and adolescents. | 2013 | Details |
| A23763 | 23504926 | Hepatology | Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial). | 2013 | Details |
| A23764 | 23504808 | Hepatology | Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association? | 2013 | Details |
| A23766 | 23503837 | J Gastroenterol | Oral choline tolerance test as a novel noninvasive method for predicting nonalcoholic steatohepatitis. | 2013 | Details |
| A23768 | 23500152 | J Hepatol | Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome. | 2013 | Details |
| A23769 | 23499441 | Cell Rep | Increased expression of enzymes of triglyceride synthesis is essential for the development of hepatic steatosis. | 2013 | Details |
| A23770 | 23497552 | BMC Res Notes | Morphological and metabolic determinants of nonalcoholic fatty liver disease in obese youth: a pilot study. | 2013 | Details |
| A23771 | 23496113 | Pediatr Transplant | Pediatric post-transplant metabolic syndrome: new clouds on the horizon. | 2013 | Details |
| A23772 | 24843641 | J Diabetes Investig | Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas. | 2013 | Details |
| A23773 | 23493072 | Curr Opin Gastroenterol | Paediatric nonalcoholic fatty liver disease. | 2013 | Details |
| A23774 | 23492572 | Clin Chem Lab Med | Study of an elevated carbohydrate antigen 19-9 concentration in a large health check-up cohort in China. | 2013 | Details |
| A23775 | 23492103 | Gut | Molecular interplay between Δ5/Δ6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis. | 2013 | Details |
| A23776 | 23489555 | Basic Clin Pharmacol Toxicol | Effects of antihypertensive and triglyceride lowering agents on splenocyte apoptosis in rats with fatty liver. | 2013 | Details |
| A23777 | 23489256 | Hepatol Res | Efficacy and safety in sitagliptin therapy for diabetes complicated by non-alcoholic fatty liver disease. | 2013 | Details |
| A23778 | 23488792 | J Gastroenterol Hepatol | Antigen peptide transporter 1 is involved in the development of fructose-induced hepatic steatosis in mice. | 2013 | Details |
| A23779 | 23486619 | Med Ultrason | Quantitative measurement of ultrasound attenuation and Hepato-Renal Index in Non-Alcoholic Fatty Liver Disease. | 2013 | Details |
| A23780 | 23486573 | Bull Exp Biol Med | Characteristics of heme oxygenase-1 expression in rat hepatocytes during the development of nonalcoholic steatohepatitis. | 2013 | Details |
| A23781 | 23485520 | J Hepatol | The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. | 2013 | Details |
| A23782 | 23484035 | PLoS One | Susceptibility and gene interaction study of the angiotensin II type 1 receptor (AGTR1) gene polymorphisms with non-alcoholic fatty liver disease in a multi-ethnic population. | 2013 | Details |
| A23783 | 23483818 | World J Gastroenterol | From fatty liver to fibrosis: a tale of "second hit". | 2013 | Details |
| A23784 | 23482703 | World J Gastroenterol | NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients. | 2013 | Details |
| A23785 | 23482433 | Korean J Pediatr | Noninvasive diagnosis of pediatric nonalcoholic fatty liver disease. | 2013 | Details |
| A23786 | 23482247 | World J Gastroenterol | Fructose as a key player in the development of fatty liver disease. | 2013 | Details |
| A23787 | 23480804 | Expert Opin Med Diagn | Liver fibrosis in patients with non-alcoholic fatty liver disease: diagnostic options in clinical practice. | 2012 | Details |
| A23788 | 23480803 | Expert Opin Med Diagn | Transient elastography and serum biomarkers: two-step screening methods for liver fibrosis in non-alcoholic fatty liver disease before liver biopsy. | 2012 | Details |
| A23789 | 23480577 | Eur J Clin Invest | Nonalcoholic fatty liver in nondiabetic patients with acute coronary syndromes. | 2013 | Details |
| A23790 | 23478936 | J Gastroenterol | Serum metabolomic profile and potential biomarkers for severity of fibrosis in nonalcoholic fatty liver disease. | 2013 | Details |
| A23791 | 23478717 | Nutr Hosp | Influence of G1359A polimorphysm of the cannabinoid receptor gene (CNR1) on insulin resistance and adipokines in patients with non alcoholic fatty liver disease. | 2013 | Details |